Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02514447
Brief Title: Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy

First Submitted : July 31, 2015
First Submitted that Met QC Criteria : July 31, 2015
First Posted : August 3, 2015 (Estimate)

Certification/Extension First Submitted : July 23, 2019
Certification/Extension First Submitted that Met QC Criteria : July 23, 2019
Certification/Extension First Posted : July 31, 2019

Last Update Submitted that Met QC Criteria : August 21, 2019
Last Update Posted : August 27, 2019 (Estimate)